Market Capitalization (Millions $) |
49 |
Shares
Outstanding (Millions) |
54 |
Employees |
- |
Revenues (TTM) (Millions $) |
21 |
Net Income (TTM) (Millions $) |
-119 |
Cash Flow (TTM) (Millions $) |
-10 |
Capital Exp. (TTM) (Millions $) |
2 |
Cara Therapeutics Inc
Cara Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing new chemical entities to alleviate pain and pruritus. The company primarily utilizes its proprietary drug delivery technology to develop novel therapeutics that target the body's peripheral nervous system. Cara Therapeutics' investigational drugs are being developed for various diseases such as chronic kidney disease-associated pruritus, atopic dermatitis, and osteoarthritis. The company aims to provide effective and well-tolerated treatment options for patients suffering from pain and itching.
Company Address: 400 Atlantic Street Stamford 6901 CT
Company Phone Number: 406-3700 Stock Exchange / Ticker: NASDAQ CARA
|